MTOR and cancer: It has been reported that biological processes such as epithelial–mesenchymal transition (EMT) [25, 26], PI3K/AKT/mTOR signaling pathway [27], hypoxia [28], and cell cycle [29] play important regulatory roles in cancer progression.